Based on the impressive success of the first phase of his clinical trial, Dr. Czerniecki and his staff at the University of Pennsylvania are excited to announce the 2nd phase clinical trial for a breast cancer vaccine.
This study involves using your own cells to develop a vaccine that will attack cancer and prevent it from growing. Upon entering the study, your blood will be drawn in a way that allows us to collect only your white blood cells. These cells will be used to create a vaccine, which you will receive weekly over a six-week period. After you receive the vaccine, you will undergo the standard surgical procedure to remove any remaining DCIS in the breast. Your doctor will stay actively involved throughout your trial participation.
The trial is open, and there are spots for patients available - if you have been diagnosed, or know someone who has been diagnosed, and have not yet had surgery - you might be eligible to participate in the trial.
The faster we fill the spots in the trial, the sooner progress can be reported,
and the sooner we move forward.
For information please contact:
Jeanne Schueller, Research Project Manager, Department of Surgery
Jeanne can also put you in touch with lay volunteers who have knowledge of the vaccines.
Please tell all your contacts about this, so that anyone diagnosed with breast cancer can find out if they are eligible for this trial prior to surgery!!!